Shuttle Pharmaceuticals Holdings, Inc. Q2 2026: Revenue $0 Net loss $(3.15M), EPS $(3.10) — 10-Q Summary

Shuttle Pharmaceuticals Holdings, Inc. reported second-quarter 2026 results reflecting a continuing transition of the business, with revenue of $0 and a net loss of $(3.15M), or diluted loss per share of $(3.10), compared with a net loss of $(3.71M) and diluted loss per share of $(32.91) in the yea…